How many studies have been conducted on Eosinophil Derived Neurotoxin?

BiohacksAI has indexed 300 PubMed studies on Eosinophil Derived Neurotoxin, including 5 randomized controlled trials (RCTs). 49% of studies involve human subjects.

What are the main research areas for Eosinophil Derived Neurotoxin?

The primary research domains for Eosinophil Derived Neurotoxin are 🫁 Respiratory, 🔬 Inflammation, 🔬 Oncology. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Eosinophil Derived Neurotoxin

A 19-kDa cationic peptide found in EOSINOPHIL granules. Eosinophil-derived neurotoxin is a RIBONUCLEASE and may play a role as an endogenous antiviral agent.

300+ PubMed studies analyzed · 5 RCTs · Evidence Score: 46.2

Research Domains

Eosinophil Derived Neurotoxin has been studied across 15 research domains including 🫁 Respiratory, 🔬 Inflammation, 🔬 Oncology, 🛡️ Immunity, 🦠 Gut & Microbiome. The primary research focus is 🫁 Respiratory with 27% of studies addressing this area.

Loading evidence profile...

This evidence profile for Eosinophil Derived Neurotoxin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.